Families Seek Review Over Suspended Doctor Care at South London Hospital 2026

Key Points

• Call for Independent Oversight: Legal representatives acting on behalf of affected families are calling for an independent review into the medical care received by over 200 patients treated for lung conditions.
• Regulatory Action: Consultant respiratory physician Dr Veronica Varney has been placed under interim practice restrictions by the General Medical Council (GMC) following her departure from the hospital trust in 2023.
• Expert Findings: A review by the Royal College of Physicians (RCP) concluded that clinical deviations and delayed access to standard treatments potentially contributed to three premature deaths and irreversible lung harm.
• Outdated Advice: The clinician reportedly provided non-evidence-based instructions to patients, including advising some individuals with interstitial lung disease (ILD) to avoid the annual influenza vaccination and rapeseed oil.
• Internal Hospital Audit: An internal review conducted by St George’s, Epsom and St Helier University Hospitals and Health Group identified 216 cases where care failed to meet best practice standards, during which 91 of those patients subsequently died.

South London (South London News) August 11, 2026 – Legal representatives and bereaved families have called for a comprehensive, independent review into the care provided to more than 200 patients treated by a suspended hospital consultant whose clinical practices have been linked to severe patient harm and three premature deaths. The demand comes in the wake of formal regulatory action taken against Dr Veronica Varney, a former consultant respiratory physician at St Helier Hospital in south London, who was placed under interim restrictions by the General Medical Council (GMC).

What were the key findings of the Royal College of Physicians review?

As reported by Storm Newton of PA Media, an investigation commissioned by St George’s, Epsom and St Helier University Hospitals and Health Group (GESH) and conducted by the Royal College of Physicians (RCP) examined a sample of 28 patient cases managed between 2019 and 2022.

The RCP panel concluded that significant departures from national clinical guidelines and delays in providing standard, evidence-based therapies “potentially contributed” to the premature deaths of three patients who missed opportunities for life-extending treatment.

As detailed by legal expert Maria Repanos of Hudgell Solicitors, the expert panel found that Dr Varney repeatedly initiated

“non-evidence-based and off-label treatments”

for interstitial lung disease without documented clinical rationale or clear evidence of informed patient consent. The report highlighted that the consultant demonstrated a

“poor interpretation of lung function test results”

and routinely failed to engage with multidisciplinary teams (MDTs), which are considered essential for managing complex respiratory conditions.

Furthermore, the investigation revealed that patients were given unconventional advice, such as instructions to avoid rapeseed oil and to decline the seasonal influenza vaccine—a guidance directly contrary to established medical consensus for vulnerable respiratory patients.

How extensive were the clinical failures identified within the NHS Trust?

As published in legal updates by Setfords Legal, an internal audit conducted by the NHS Trust into 216 cases managed by Dr Varney between 2019 and 2023 uncovered widespread system and individual failures:

• Lack of Referral: In 42 per cent of cases, patients were never referred to a specialist ILD multidisciplinary team, isolating them from collaborative expert care.
• Absence of Treatment: In 30 per cent of cases, patients received no treatment whatsoever despite suffering from progressive, debilitating lung conditions.
• Diagnostic Shortfalls: In 20 per cent of cases, patients were not provided with adequate diagnostic investigations, leaving them without an accurate assessment of their illness.
• Inappropriate Prescriptions: In 9 per cent of cases, patients were prescribed therapies deemed entirely unsuitable for their specific respiratory condition.

As reported by Fletchers Solicitors, out of the 216 patients identified in the trust’s initial audit whose care fell below required standards, 91 have since passed away, prompting urgent demands from legal teams to establish the full extent to which clinical omissions played a role in these fatalities.

Why were concerns not acted upon sooner?

As noted by Patient Safety Learning, early red flags regarding Dr Varney’s clinical practices were repeatedly raised by junior doctors, trainees, and through internal whistleblower channels between 2019 and 2022.

However, the trust failed to take decisive action during this period, later attributing part of the delay in addressing these internal warnings to operational disruptions caused by the COVID-19 pandemic.

Dr Varney was eventually restricted from seeing patients in January 2023 and subsequently left the hospital group later that year.

The trust formally referred her to the GMC in September 2024, resulting in interim conditions being placed on her medical registration.

These restrictions mandate that she must inform the regulator before taking up any clinical post and personally notify relevant authorities of the conditions imposed on her practice. GESH executive leadership has acknowledged that the clinician should have been stopped from treating patients much earlier.

Explore More Local South London News

How Range Rover Alloy Wheels Can Give Your SUV a Stylish New Look

Man Surgery After Victoria Line Attack South London 2026

Background of the particular development

Interstitial lung disease (ILD) serves as an overarching medical term covering more than 200 chronic disorders characterized by progressive inflammation and scarring (fibrosis) of the tissue surrounding the air sacs in the lungs. Conditions within this category include idiopathic pulmonary fibrosis (IPF) and hypersensitivity pneumonitis.

Because progressive fibrosis impairs the lungs’ capacity to transfer oxygen into the bloodstream, early diagnostic accuracy, timely administration of anti-fibrotic or immunosuppressive medications, and referral to specialist tertiary centres are vital to slow disease progression and extend patient survival.

At St Helier Hospital, respiratory services for ILD patients relied heavily on individual consultant oversight. National clinical standards set by bodies such as the National Institute for Health and Care Excellence (NICE) require that all ILD cases be reviewed by a specialist multidisciplinary team—comprising consultant radiologists, pathologists, thoracic surgeons, and specialized nurses—to ensure consensus on complex diagnoses and treatment plans.

The failure to utilize these established frameworks over a four-year period allowed non-standard clinical practices to continue undetected until internal whistleblowers and trainee reports forced a formal audit.

Prediction: How this development can affect NHS patients, healthcare professionals, and hospital governance

The escalation of this case to formal regulatory restrictions and widespread legal claims is expected to trigger significant structural and operational changes across the National Health Service (NHS), affecting several key groups:

• Impact on Affected Patients and Families: For the families of the 216 patients involved, the ongoing investigations will likely lead to multi-claim legal actions against the NHS trust to secure financial compensation and clinical accountability. Patients currently living with irreversible lung damage due to delayed interventions may require updated, specialized clinical reassessments to stabilize their conditions.
• Impact on NHS Governance and Whistleblowing Systems: The acknowledged failure to act on early warnings raised between 2019 and 2022 will likely pressure health regulators, including the Care Quality Commission (CQC), to enforce stricter oversight on how hospital trusts handle internal whistleblowing reports. NHS trusts across the UK may be mandated to audit single-consultant clinics to ensure strict adherence to multidisciplinary team protocols.
• Impact on Healthcare Professionals: Consultant physicians and clinical leads will face heightened scrutiny regarding compliance with national guidelines and the documented use of off-label treatments. Trainee doctors may benefit from reinforced protection mechanisms when reporting senior clinical deviations, ensuring that patient safety concerns are escalated without fear of professional reprisal.